CAMBRIDGE, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

Citi’s 2023 18^th Annual BioPharma Conference
1x1 Investor Meetings: Thursday, September 7, 2023
Location: Four Seasons Hotel, Boston, MA

H.C. Wainwright 25th Annual Global Investment Conference (Hybrid)
Virtual Presentation: Monday, September 11, 2023
Location: Lotte New York Palace Hotel, New York, NY

Baird’s 2023 Global Healthcare Conference
Presentation: Wednesday, September 13, 2023 at 9:05 am ET
Location: Intercontinental New York Barclay, New York, NY

Morgan Stanley 21^st Annual Global Healthcare Conference
Fireside Chat: Wednesday, September 13, 2023 at 4:15 pm ET
Location: Sheraton Hotel, New York, NY

Live webcasts and archived replays of the presentation at the H.C. Wainwright 25^th Annual Global Investment Conference and the fireside chat at the Morgan Stanley 21^st Annual Global Healthcare Conference will be available on the investors section of www.vorbio.com.

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com